Amadori, Letizia http://orcid.org/0000-0003-1125-4631
Calcagno, Claudia
Fernandez, Dawn M.
Koplev, Simon
Fernandez, Nicolas
Kaur, Ravneet
Mury, Pauline
Khan, Nayaab S
Sajja, Swathy
Shamailova, Roza
Cyr, Yannick http://orcid.org/0000-0002-0715-4112
Jeon, Minji
Hill, Christopher A. http://orcid.org/0000-0003-3302-3658
Chong, Peik Sean
Naidu, Sonum
Sakurai, Ken
Ghotbi, Adam Ali
Soler, Raphael
Eberhardt, Natalia http://orcid.org/0000-0002-3309-4563
Rahman, Adeeb
Faries, Peter
Moore, Kathryn J. http://orcid.org/0000-0003-2505-2547
Fayad, Zahi A.
Ma’ayan, Avi http://orcid.org/0000-0002-6904-1017
Giannarelli, Chiara http://orcid.org/0000-0003-2473-6058
Article History
Received: 26 July 2022
Accepted: 28 April 2023
First Online: 8 June 2023
Change Date: 4 July 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s44161-023-00310-1
Competing interests
: C.G. is listed as an inventor on patent application Tech 160808G PCT/US2022/017777, filed by the Icahn School of Medicine at Mount Sinai (patent applicant), that is directly related to the method used in this manuscript to identify saracatinib as an antiatherosclerotic agent. The remaining authors declare no competing interests.